Pakistan vs United States: Proportion of isolates with decreased susceptibility or resistance
Pakistan
0
in 2019
United States
0
in 2020
Pakistan rank
13th
United States rank
13th
Proportion of isolates with decreased susceptibility or resistance over time
- Pakistan
- United States
How they compare
Pakistan currently reports 0 against 0 in United States, a difference of 0.
The two have swapped places 2 times across 5 shared years of data; in 2011 it was United States ahead.
Pakistan ranks 13th and United States ranks 13th of 52 countries.
Pakistan has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Pakistan or United States?
- Pakistan, at 0 against 0 in United States as of 2019.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Pakistan and United States?
- 0, with Pakistan ahead.
- How many years of comparable data are there for Pakistan and United States?
- 5 years are reported by both, from 2011 to 2018.
- How do Pakistan and United States rank globally for proportion of isolates with decreased susceptibility or resistance?
- Pakistan ranks 13th and United States ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.